Product Information
BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0219 per EA under NDC 00904712261. Its NADAC has been published 223 times since Mar 23, 2022.
The Low Outlier badge above means this manufacturer's average price in the Buspirone Hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904712261
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204582On Market Since
6/29/2012
Price Statistics
The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 223 times since Mar 23, 2022, and over the history we have for it it has declined 23.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0219 per EA |
|---|---|
| All-time high | $0.0314 (Nov 16, 2022) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0232 |
| 52-week low | $0.0214 |
| Median price | $0.0242 |
| Average price | $0.0246 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 223 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0219 per EA (NDC 00904712261), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 23.3%. It has been tracked across 223 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?
Since Mar 23, 2022, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0314 (Nov 16, 2022), with a median of $0.0242 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 5 MG TABLET?
BUSPIRONE HCL 5 MG TABLET (NDC 00904712261) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification